Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$73.74
$64.17
$54.11
$89.98
$28.45B1.456.90 million shs9.26 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$62.34
$67.68
$58.75
$89.77
$28.36B0.745.10 million shs5.61 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$424.59
0.0%
$453.54
$414.30
$603.88
$150.37B1.462.24 million shs3.44 million shs
Medtronic PLC stock logo
MDT
Medtronic
$73.73
-0.1%
$82.36
$73.67
$106.33
$94.66B0.5810.09 million shs22.23 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
0.00%+2.27%+23.83%-0.05%-14.22%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.00%-2.94%+2.47%-22.23%-10.89%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%-3.08%-7.22%-14.44%-22.96%
Medtronic PLC stock logo
MDT
Medtronic
0.00%-6.27%-9.06%-24.83%-11.20%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$73.74
$64.17
$54.11
$89.98
$28.45B1.456.90 million shs9.26 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$62.34
$67.68
$58.75
$89.77
$28.36B0.745.10 million shs5.61 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$424.59
0.0%
$453.54
$414.30
$603.88
$150.37B1.462.24 million shs3.44 million shs
Medtronic PLC stock logo
MDT
Medtronic
$73.73
-0.1%
$82.36
$73.67
$106.33
$94.66B0.5810.09 million shs22.23 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
0.00%+2.27%+23.83%-0.05%-14.22%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.00%-2.94%+2.47%-22.23%-10.89%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.00%-3.08%-7.22%-14.44%-22.96%
Medtronic PLC stock logo
MDT
Medtronic
0.00%-6.27%-9.06%-24.83%-11.20%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
2.92
Moderate Buy$82.4211.77% Upside
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
2.50
Moderate Buy$80.2128.67% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.67
Moderate Buy$576.7135.83% Upside
Medtronic PLC stock logo
MDT
Medtronic
2.58
Moderate Buy$106.4544.38% Upside

Current Analyst Ratings Breakdown

Latest MDT, DXCM, GEHC, and ISRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2026
DexCom, Inc. stock logo
DXCM
DexCom
Reiterated RatingBuy$79.00 ➝ $84.00
5/27/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Set Price Target$558.00
5/21/2026
Medtronic PLC stock logo
MDT
Medtronic
DowngradeHold (C+)Hold (C)
5/21/2026
Medtronic PLC stock logo
MDT
Medtronic
Set Price TargetNeutral$84.00
5/21/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
UpgradeSellNeutral$75.00 ➝ $69.00
5/21/2026
Medtronic PLC stock logo
MDT
Medtronic
UpgradeHold$84.00
5/19/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingHold (C)
5/19/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Lower Price TargetBuy$95.00 ➝ $80.00
5/18/2026
DexCom, Inc. stock logo
DXCM
DexCom
Set Price TargetBuy$100.00 ➝ $82.00
5/18/2026
DexCom, Inc. stock logo
DXCM
DexCom
Reiterated RatingUnderweight$67.00 ➝ $64.00
5/18/2026
DexCom, Inc. stock logo
DXCM
DexCom
Lower Price TargetBuy$100.00 ➝ $80.00
(Data available from 6/1/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B6.10$2.77 per share26.63$7.04 per share10.47
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$20.63B1.37$5.88 per share10.61$22.80 per share2.73
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$10.06B14.94$9.28 per share45.77$50.52 per share8.40
Medtronic PLC stock logo
MDT
Medtronic
$33.54B2.82$7.74 per share9.52$37.62 per share1.96
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.3431.5124.421.2219.31%33.33%13.19%7/29/2026 (Estimated)
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$2.08B$4.1814.9111.591.409.10%20.46%5.73%7/29/2026 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.2551.4743.283.3928.15%15.98%14.07%7/28/2026 (Estimated)
Medtronic PLC stock logo
MDT
Medtronic
$4.66B$3.5920.5412.131.7613.00%14.82%7.88%6/3/2026 (Estimated)

Latest MDT, DXCM, GEHC, and ISRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/3/2026Q4 2026
Medtronic PLC stock logo
MDT
Medtronic
$1.54N/AN/AN/A$9.62 billionN/A
4/30/2026Q1 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.47$0.56+$0.09$0.51$1.17 billion$1.19 billion
4/29/2026Q1 2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.07$0.99-$0.08$0.85$5.04 billion$5.13 billion
4/21/2026Q1 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.140.22%N/A3.35%1 Years
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Medtronic PLC stock logo
MDT
Medtronic
$2.843.85%+5.33%79.11%49 Years

Latest MDT, DXCM, GEHC, and ISRG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/5/2026
Medtronic PLC stock logo
MDT
Medtronic
quarterly$0.713.26%3/27/20263/27/20264/17/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.42
1.95
1.64
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.95
1.22
0.95
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.61
3.59
Medtronic PLC stock logo
MDT
Medtronic
0.57
2.54
1.87

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
82.06%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Medtronic PLC stock logo
MDT
Medtronic
82.06%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.36%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
Medtronic PLC stock logo
MDT
Medtronic
0.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000385.87 million384.79 millionOptionable
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
54,000454.89 million453.25 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021354.16 million352.04 millionOptionable
Medtronic PLC stock logo
MDT
Medtronic
95,0001.28 billion1.28 billionOptionable

Recent News About These Companies

Medtronic: Cheap And Acquisitive
PODD Stock: What a Hold Rating Says at a $163 Target
Medtronic’s Evolut displays superior clinical outcomes
NPCE Explains How NeuroPace's RNS System Makes Money
Medtronic (MDT) Expected to Announce Earnings on Wednesday

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
DexCom stock logo

DexCom NASDAQ:DXCM

$73.74 0.00 (0.00%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$73.35 -0.39 (-0.53%)
As of 05/29/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

GE HealthCare Technologies stock logo

GE HealthCare Technologies NASDAQ:GEHC

$62.34 0.00 (0.00%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$62.45 +0.11 (+0.18%)
As of 05/29/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$424.59 -0.05 (-0.01%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$424.70 +0.11 (+0.03%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Medtronic stock logo

Medtronic NYSE:MDT

$73.73 -0.08 (-0.11%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$74.16 +0.43 (+0.58%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.